tetrakis(chloropalladium(1+));2-[3-[1-methyl-5-(4-phenylphenyl)imidazol-2-yl]benzene-2-id-1-yl]oxypyridine;5-(4-phenylphenyl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1,3-oxazole;2-[3-[4-(4-phenylphenyl)triazol-1-yl]benzene-2-id-1-yl]oxypyridine;2-[3-[4-(4-phenylphenyl)triazol-2-yl]benzene-2-id-1-yl]oxypyridine

C103H71Cl4N13O5Pd4 — CID 159577001

About tetrakis(chloropalladium(1+));2-[3-[1-methyl-5-(4-phenylphenyl)imidazol-2-yl]benzene-2-id-1-yl]oxypyridine;5-(4-phenylphenyl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1,3-oxazole;2-[3-[4-(4-phenylphenyl)triazol-1-yl]benzene-2-id-1-yl]oxypyridine;2-[3-[4-(4-phenylphenyl)triazol-2-yl]benzene-2-id-1-yl]oxypyridine

tetrakis(chloropalladium(1+));2-[3-[1-methyl-5-(4-phenylphenyl)imidazol-2-yl]benzene-2-id-1-yl]oxypyridine;5-(4-phenylphenyl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1,3-oxazole;2-[3-[4-(4-phenylphenyl)triazol-1-yl]benzene-2-id-1-yl]oxypyridine;2-[3-[4-(4-phenylphenyl)triazol-2-yl]benzene-2-id-1-yl]oxypyridine (PubChem CID 159577001) has the molecular formula C103H71Cl4N13O5Pd4 and a molecular weight of 2138.28 g/mol. Its IUPAC name is tetrakis(chloropalladium(1+));2-[3-[1-methyl-5-(4-phenylphenyl)imidazol-2-yl]benzene-2-id-1-yl]oxypyridine;5-(4-phenylphenyl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1,3-oxazole;2-[3-[4-(4-phenylphenyl)triazol-1-yl]benzene-2-id-1-yl]oxypyridine;2-[3-[4-(4-phenylphenyl)triazol-2-yl]benzene-2-id-1-yl]oxypyridine.

Molecular Properties

• Compound Name: tetrakis(chloropalladium(1+));2-[3-[1-methyl-5-(4-phenylphenyl)imidazol-2-yl]benzene-2-id-1-yl]oxypyridine;5-(4-phenylphenyl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1,3-oxazole;2-[3-[4-(4-phenylphenyl)triazol-1-yl]benzene-2-id-1-yl]oxypyridine;2-[3-[4-(4-phenylphenyl)triazol-2-yl]benzene-2-id-1-yl]oxypyridine
• PubChem CID: 159577001
• Molecular Formula: C103H71Cl4N13O5Pd4
• Molecular Weight: 2138.28 g/mol
• Exact Mass: 2133.06
• IUPAC Name: tetrakis(chloropalladium(1+));2-[3-[1-methyl-5-(4-phenylphenyl)imidazol-2-yl]benzene-2-id-1-yl]oxypyridine;5-(4-phenylphenyl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1,3-oxazole;2-[3-[4-(4-phenylphenyl)triazol-1-yl]benzene-2-id-1-yl]oxypyridine;2-[3-[4-(4-phenylphenyl)triazol-2-yl]benzene-2-id-1-yl]oxypyridine
• SMILES: Cl[Pd+].Cl[Pd+].Cl[Pd+].Cl[Pd+].Cn1c(-c2ccc(-c3ccccc3)cc2)cnc1-c1[c-]c(Oc2ccccn2)ccc1.[c-]1c(Oc2ccccn2)cccc1-c1ncc(-c2ccc(-c3ccccc3)cc2)o1.[c-]1c(Oc2ccccn2)cccc1-n1cc(-c2ccc(-c3ccccc3)cc2)nn1.[c-]1c(Oc2ccccn2)cccc1-n1ncc(-c2ccc(-c3ccccc3)cc2)n1
• InChI: InChI=1S/C27H20N3O.C26H17N2O2.2C25H17N4O.4ClH.4Pd/c1-30-25(22-15-13-21(14-16-22)20-8-3-2-4-9-20)19-29-27(30)23-10-7-11-24(18-23)31-26-12-5-6-17-28-26;1-2-7-19(8-3-1)20-12-14-21(15-13-20)24-18-28-26(30-24)22-9-6-10-23(17-22)29-25-11-4-5-16-27-25;1-2-7-19(8-3-1)20-12-14-21(15-13-20)24-18-29(28-27-24)22-9-6-10-23(17-22)30-25-11-4-5-16-26-25;1-2-7-19(8-3-1)20-12-14-21(15-13-20)24-18-27-29(28-24)22-9-6-10-23(17-22)30-25-11-4-5-16-26-25;;;;;;;;/h2-17,19H,1H3;3*1-16,18H;4*1H;;;;/q4*-1;;;;;4*+2/p-4
• InChIKey: KEPDDLGPZYKTHS-UHFFFAOYSA-J
• XLogP: 27.00
• TPSA: 193.75 Ų
• H-Bond Acceptors: 18
• Rotatable Bonds: 20
• Heavy Atoms: 129
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2138.28
LogP ≤ 5	27.00
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	18

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of tetrakis(chloropalladium(1+));2-[3-[1-methyl-5-(4-phenylphenyl)imidazol-2-yl]benzene-2-id-1-yl]oxypyridine;5-(4-phenylphenyl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1,3-oxazole;2-[3-[4-(4-phenylphenyl)triazol-1-yl]benzene-2-id-1-yl]oxypyridine;2-[3-[4-(4-phenylphenyl)triazol-2-yl]benzene-2-id-1-yl]oxypyridine?

The IUPAC name of tetrakis(chloropalladium(1+));2-[3-[1-methyl-5-(4-phenylphenyl)imidazol-2-yl]benzene-2-id-1-yl]oxypyridine;5-(4-phenylphenyl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1,3-oxazole;2-[3-[4-(4-phenylphenyl)triazol-1-yl]benzene-2-id-1-yl]oxypyridine;2-[3-[4-(4-phenylphenyl)triazol-2-yl]benzene-2-id-1-yl]oxypyridine (CID 159577001) is tetrakis(chloropalladium(1+));2-[3-[1-methyl-5-(4-phenylphenyl)imidazol-2-yl]benzene-2-id-1-yl]oxypyridine;5-(4-phenylphenyl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1,3-oxazole;2-[3-[4-(4-phenylphenyl)triazol-1-yl]benzene-2-id-1-yl]oxypyridine;2-[3-[4-(4-phenylphenyl)triazol-2-yl]benzene-2-id-1-yl]oxypyridine.

What is the SMILES notation for tetrakis(chloropalladium(1+));2-[3-[1-methyl-5-(4-phenylphenyl)imidazol-2-yl]benzene-2-id-1-yl]oxypyridine;5-(4-phenylphenyl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1,3-oxazole;2-[3-[4-(4-phenylphenyl)triazol-1-yl]benzene-2-id-1-yl]oxypyridine;2-[3-[4-(4-phenylphenyl)triazol-2-yl]benzene-2-id-1-yl]oxypyridine?

The canonical SMILES for tetrakis(chloropalladium(1+));2-[3-[1-methyl-5-(4-phenylphenyl)imidazol-2-yl]benzene-2-id-1-yl]oxypyridine;5-(4-phenylphenyl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1,3-oxazole;2-[3-[4-(4-phenylphenyl)triazol-1-yl]benzene-2-id-1-yl]oxypyridine;2-[3-[4-(4-phenylphenyl)triazol-2-yl]benzene-2-id-1-yl]oxypyridine is Cl[Pd+].Cl[Pd+].Cl[Pd+].Cl[Pd+].Cn1c(-c2ccc(-c3ccccc3)cc2)cnc1-c1[c-]c(Oc2ccccn2)ccc1.[c-]1c(Oc2ccccn2)cccc1-c1ncc(-c2ccc(-c3ccccc3)cc2)o1.[c-]1c(Oc2ccccn2)cccc1-n1cc(-c2ccc(-c3ccccc3)cc2)nn1.[c-]1c(Oc2ccccn2)cccc1-n1ncc(-c2ccc(-c3ccccc3)cc2)n1.

What is the InChIKey of tetrakis(chloropalladium(1+));2-[3-[1-methyl-5-(4-phenylphenyl)imidazol-2-yl]benzene-2-id-1-yl]oxypyridine;5-(4-phenylphenyl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1,3-oxazole;2-[3-[4-(4-phenylphenyl)triazol-1-yl]benzene-2-id-1-yl]oxypyridine;2-[3-[4-(4-phenylphenyl)triazol-2-yl]benzene-2-id-1-yl]oxypyridine?

The InChIKey is KEPDDLGPZYKTHS-UHFFFAOYSA-J. The full InChI is InChI=1S/C27H20N3O.C26H17N2O2.2C25H17N4O.4ClH.4Pd/c1-30-25(22-15-13-21(14-16-22)20-8-3-2-4-9-20)19-29-27(30)23-10-7-11-24(18-23)31-26-12-5-6-17-28-26;1-2-7-19(8-3-1)20-12-14-21(15-13-20)24-18-28-26(30-24)22-9-6-10-23(17-22)29-25-11-4-5-16-27-25;1-2-7-19(8-3-1)20-12-14-21(15-13-20)24-18-29(28-27-24)22-9-6-10-23(17-22)30-25-11-4-5-16-26-25;1-2-7-19(8-3-1)20-12-14-21(15-13-20)24-18-27-29(28-24)22-9-6-10-23(17-22)30-25-11-4-5-16-26-25;;;;;;;;/h2-17,19H,1H3;3*1-16,18H;4*1H;;;;/q4*-1;;;;;4*+2/p-4.

What are the key properties of tetrakis(chloropalladium(1+));2-[3-[1-methyl-5-(4-phenylphenyl)imidazol-2-yl]benzene-2-id-1-yl]oxypyridine;5-(4-phenylphenyl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1,3-oxazole;2-[3-[4-(4-phenylphenyl)triazol-1-yl]benzene-2-id-1-yl]oxypyridine;2-[3-[4-(4-phenylphenyl)triazol-2-yl]benzene-2-id-1-yl]oxypyridine?

tetrakis(chloropalladium(1+));2-[3-[1-methyl-5-(4-phenylphenyl)imidazol-2-yl]benzene-2-id-1-yl]oxypyridine;5-(4-phenylphenyl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1,3-oxazole;2-[3-[4-(4-phenylphenyl)triazol-1-yl]benzene-2-id-1-yl]oxypyridine;2-[3-[4-(4-phenylphenyl)triazol-2-yl]benzene-2-id-1-yl]oxypyridine has a molecular weight of 2138.28 g/mol, XLogP of 27.00, 20 rotatable bonds, 0 hydrogen bond donors, and 18 hydrogen bond acceptors.

Where does this data come from?

All data for tetrakis(chloropalladium(1+));2-[3-[1-methyl-5-(4-phenylphenyl)imidazol-2-yl]benzene-2-id-1-yl]oxypyridine;5-(4-phenylphenyl)-2-(3-pyridin-2-yloxybenzene-2-id-1-yl)-1,3-oxazole;2-[3-[4-(4-phenylphenyl)triazol-1-yl]benzene-2-id-1-yl]oxypyridine;2-[3-[4-(4-phenylphenyl)triazol-2-yl]benzene-2-id-1-yl]oxypyridine is sourced from PubChem (CID 159577001), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).